Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence

Abstract

This article summarises the current evidence on the risk of venous thromboembolism (VTE) with the use of antipsychotics. An increasing number of observational studies indicate an elevated risk of VTE in antipsychotic drug users. Although the use of certain antipsychotics has been associated with VTE, current data can neither conclusively verify differences in occurrence rates of VTE between first- and second-generation antipsychotics or between individual compounds, nor identify which antipsychotic drugs have the lowest risk of VTE. The biological mechanisms involved in the pathogenesis of this adverse drug reaction are still to be clarified but hypotheses such as drug-induced sedation, obesity, increased levels of antiphospholipid antibodies, enhanced platelet aggregation, hyperhomocysteinaemia and hyperprolactinaemia have been suggested. Risk factors associated with the underlying psychiatric disorder may at least partly explain the increased risk. Physicians should be aware of this potentially serious and even sometimes fatal adverse drug reaction and should consider discontinuing or switching the antipsychotic treatment in patients experiencing a VTE. Even though supporting evidence is limited, prophylactic antithrombotic treatment should be considered in risk situations for VTE.

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

“…Antipsychotics have been clearly shown to be associated with an increased risk of thromboembolism in large observational studies, with an arguably higher risk in vulnerable populations with pre-existing risk factors [70] ( Table 1). It is still uncertain if there are relevant differences in risk between individual agents [108].…”

Women who suffer from schizophrenia: Critical issues

“…There are many such factors, however, including ethnicity[ 120 ]. Despite the many contributing factors, pregnant women on APs have been shown to be at significantly higher risk for venous thromboembolism than pregnant women in the general population[ 121 , 122 ].…”

Two pulmonary emboli in a psych pod

“…Psychiatric patients are not only at risk secondary to factors related to restraint and hospitalization, but also because of stress and medication. Decompensated psychiatric patients are more prone to stress and with that, increased catecholamine surges, increase in acute phase reactants, sedentariness secondary to disease or medication, as well as medication side effects 8,9 . Current antipsychotic use has been associated with a significantly increased risk of developing venous thromboembolism 10 .…”